Abstract
DIAGNOSIS OF TUBERCULOSIS IN PLHIV PATIENTS BY USING THE XPERT® MTB/RIF ASSAY: A CLINICAL STUDY

Dr. Atul Kharate, Dr. Vijay Agrwal, Dr. Vijay Chhajlani, Dr. Jyoti Khurana*, Neha Dawar, Amit Verma, Dhwani Patel and Nagmi Aliya Ansari

ABSTRACT

Objective: Tuberculosis (TB) is one of the commonest opportunistic infection and the leading cause of death in HIV patients in developing countries. HIV infection is a well recognised risk factor for both activation of initial infection and reactivation of latent infection. This study was done to find out the co-prevalence and the trend of HIV infection among tuberculosis patients and to determine the prevalence of MDR Tuberculosis in HIV positive patients using Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, United States). Materials and Methods: The sputum samples are received from Indore M.P, India. Sputum samples of the patients with symptoms suggestive of pulmonary tuberculosis including both new cases and on treatment are received from the various DMCs and hospitals. Sputum specimen was processed for TB detection by Cartridge Based Nucleic Acid Amplification testing (CB-NAAT) using Xpert MTB/RiF assay technology. Results: The study period is from 2015 to August 2016. A total of 4595 patients with symptoms suggestive of pulmonary tuberculosis including both new cases and on treatment. Out of these patients 1087 were reported MTB detected. Out of these 4595 patients 953 were reported HIV positive and out of 953 patients 127(13.3%) were reported positive for (HIV +TUBERCULOSIS). Of these 127 cases 118(92.9%) cases were sensitive to rifampicin (RIF) and 9(7%) cases were showing resistance to rifampicin (RIF) Drug. Conclusion: Co-existence of HIV and tuberculosis is high and there is high Prevalence of MDR tuberculosis in HIV patients.

Keywords: Co-infection, Cartridge based nucleic acid amplification testing, Human immunodeficiency virus (HIV), Pulmonary, Rifampicin, Tuberculosis.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT